查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1610000

非鸦片类镇痛贴片市场规模、份额和趋势分析报告：按贴片类型、分销管道、地区、细分市场预测，2025-2030

Non-opioid Pain Patches Market Size, Share & Trends Analysis Report By Patch Type (Lidocaine, Diclofenac, Methyl Salicylate, Capsaicin, Ketoprofen), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

非阿片类止痛贴片市场成长与趋势

Grand View Research, Inc.最新报告显示，到2030年，全球非鸦片类止痛贴片市场规模预计将达到14亿美元，预测期间内复合年增长率为6.2%。推动市场的关键因素包括疼痛相关疾病的盛行率上升以及这些贴片提供的品种与用于缓解急性和慢性疼痛的其他形式的药物相比具有优势。

根据 AAPM 的数据，在美国，慢性疼痛缓解所影响的人数比癌症、糖尿病和心臟疾病的总合还要多。美国脊骨神经医学协会估计，美国公民每年至少花费 500 亿美元用于治疗背部相关疾病。这些事实显示全世界对止痛治疗方法的需求日益增长。

阿片类药物通常被用来治疗疼痛和相关病症，但大多数患者会产生依赖性和滥用。对鸦片类药物的依赖日益增加，促使许多国家开发替代疗法来缓解不适。 2017年11月，美国鸦片类药物流行病被宣布进入国家紧急状态。因此，各国政府要求安全有效的治疗方法，以减少副作用并缓解潜在的不适，从而加速市场成长。

根据药物滥用和心理健康服务管理局 2015 年发布的一项新研究，美国三分之一的成年人曾由医疗保健提供者开立止痛药。报告的统计数据也显示，这些药物的使用量超过了香烟、雪茄和无烟烟草的总和。大多数这些口服药物被归类为鸦片类药物，通常具有高度成瘾性，并且很容易与其他消耗品（例如酒精或其他药物）混合使用。人们对这些药物相关副作用的认识不断提高，导致了替代品的开发，例如非阿片类镇痛贴剂，可提供相同的治疗效果并有助于疼痛管理。

非阿片类镇痛贴片市场报告亮点

  • 2024年，莱可碱贴片由于其在缓解各种类型疼痛（包括神经病变镇痛和肌肉骨骼疼痛）方面的既定功效，占据了最大的市场占有率，为35.0%。
  • 零售药局在市场中占据主导地位，2024 年销售份额将达到 44.6%。市面上有多种非鸦片类止痛贴剂，无需处方即可购买。
  • 由于非阿片类镇痛贴片市场中的领导企业在当地存在，以及疼痛管理领域的研发不断增加以满足不断增长的患者群体，北美占据了最大的收益占有率。
  • 由于该地区主要企业的投资增加以及印度和中国等新兴国家製药业的发展，预计亚太地区在预测期内的复合年增长率最高。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章非鸦片类镇痛贴片市场变数、趋势与范围

  • 市场体系展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 营商环境分析
    • 产业分析-波特五力分析
    • PESTLE分析

第四章非鸦片类镇痛贴片市场：贴片类型业务分析

  • 贴片类型市场占有率，2024 年和 2030 年
  • 补丁类型细分仪表板
  • 2018-2030 年市场规模、预测与趋势分析（按补丁类型）
  • Lidocaine贴剂
  • 双氯芬酸钠贴剂
  • 水杨酸甲酯贴片
  • 辣椒素贴片
  • 酮洛芬贴剂
  • 其他（草本、薄荷醇等）

第五章非鸦片类镇痛贴片市场：通路业务分析

  • 2024 年及 2030 年分销通路市场占有率
  • 分销通路细分仪表板
  • 2018-2030 年按分销管道分類的市场规模、预测与趋势分析
  • 零售药房
  • 医院药房
  • 网路药房
  • 其他（超级市场/大卖场、DTC）

第六章非鸦片类镇痛贴片市场：贴片类型、通路、区域、估计与趋势分析

  • 2024 年及 2030 年按地区分類的市场占有率分析
  • 区域市场仪表板
  • 2018-2030年市场规模、预测趋势分析
  • 北美洲
    • 按国家/地区划分，2018-2030
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 按国家/地区划分，2018-2030
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 丹麦
    • 瑞典
  • 亚太地区
    • 按国家/地区划分，2018-2030
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 按国家/地区划分，2018-2030
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 按国家/地区划分，2018-2030
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 参与者概览
  • 公司市场分析
  • 公司分类
  • 策略规划
  • 公司简介/上市公司
    • Acorda Therapeutics, Inc.
    • Teva Pharmaceutical Industries Ltd.
    • GSK plc
    • Endo, Inc.
    • Hisamitsu Pharmaceutical Co.,Inc.
    • IBSA Institut Biochimique SA
    • Alkermes
    • Teikoku Pharma
    • Mylan NV
Product Code: GVR-4-68038-003-3

Non-opioid Pain Patches Market Growth & Trends:

The global non-opioid pain patches market size is expected to reach USD 1.4 billion by 2030, expanding at a CAGR of 6.2% during the forecast period, according to a new report by Grand View Research, Inc. Some of the key factors driving the market are rising incidence of pain related disorders and the various benefits offered by these patches over other forms of medication used to alleviate acute and chronic pain.

According to the AAPM, chronic pain affects more individuals than cancer, diabetes, and coronary heart disease combined in the U.S. Estimates from the American Chiropractic Association indicate that American citizens spend at least USD 50 billion every year on back-related ailments. These facts are indicative of the growing need for therapies to alleviate pain globally.

Opioid medications are usually sought for the treatment of pain and related disorders despite resulting in dependence and abuse in majority of patients. The rising addiction to opioid drugs has encouraged many countries to develop alternate therapies to alleviate discomfort. In November 2017, opioid epidemic in the U.S. was declared as a national emergency. Thus, demand for safe and effective therapies that ease the underlying discomfort with reduced adverse effects are sought by governments, thus accelerating the market growth.

According to a new study published by Substance Abuse and Mental Health Services Administration report in 2015, 1 in 3 adults in America were prescribed painkillers by medical providers. Statistics from the same source also indicate that these medications were used more than cigarettes, cigars, and smokeless tobacco combined. Most of these oral medicines fall under the opiate category are usually more prone to be addictive and used in combination with other consumables such as alcohol and other drugs. Growing awareness about the adverse effects associated with these drugs has led to the development of alternatives such as non-opioid pain patches to deliver the same therapeutic effect and aid in pain management.

Non-opioid Pain Patches Market Report Highlights:

  • Licodaine patches held the largest market share of 35.0% in 2024, owing to their established efficacy in alleviating various pain types, including neuropathic and musculoskeletal pain.
  • Retail pharmacies dominated the market with a revenue share of 44.6% in 2024. A variety of non-opioid pain patches are available over-the-counter, enabling customers to purchase them without prescriptions.
  • North America held the largest revenue share due to local presence of major non-opioid pain patch market players and increasing R&D in the field of pain management to cater to a rising number of patients
  • The Asia Pacific region is expected to account for the highest CAGR during the forecast period owing to rise in investments by dominant players in the region and developments in the pharmaceutical industry in emerging countries such as India and China

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Patch Type
    • 1.2.2. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Non-opioid Pain Patches Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Non-opioid Pain Patches Market: Patch Type Business Analysis

  • 4.1. Patch Type Market Share, 2024 & 2030
  • 4.2. Patch Type Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Patch Type, 2018 to 2030 (USD Million)
  • 4.4. Lidocaine Patches
    • 4.4.1. Lidocaine Patches Market, 2018 - 2030 (USD Million)
  • 4.5. Diclofenac Patches
    • 4.5.1. Diclofenac Patches Market, 2018 - 2030 (USD Million)
  • 4.6. Methyl Salicylate Patches
    • 4.6.1. Methyl Salicylate Patches Market, 2018 - 2030 (USD Million)
  • 4.7. Capsaicin Patches
    • 4.7.1. Capsaicin Patches Market, 2018 - 2030 (USD Million)
  • 4.8. Ketoprofen Patches
    • 4.8.1. Ketoprofen Patches Market, 2018 - 2030 (USD Million)
  • 4.9. Others (Herbal, Menthol, etc.)
    • 4.9.1. Others (Herbal, Menthol, etc.) Market, 2018 - 2030 (USD Million)

Chapter 5. Non-opioid Pain Patches Market: Distribution Channel Business Analysis

  • 5.1. Distribution Channel Market Share, 2024 & 2030
  • 5.2. Distribution Channel Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
  • 5.4. Retail Pharmacies
    • 5.4.1. Retail Pharmacies Market, 2018 - 2030 (USD Million)
  • 5.5. Hospital Pharmacies
    • 5.5.1. Hospital Pharmacies Market, 2018 - 2030 (USD Million)
  • 5.6. Online Pharmacies
    • 5.6.1. Online Pharmacies Market, 2018 - 2030 (USD Million)
  • 5.7. Others (Supermarkets/Hypermarkets, DTC)
    • 5.7.1. Others (Supermarkets/Hypermarkets, DTC) Market, 2018 - 2030 (USD Million)

Chapter 6. Non-opioid Pain Patches Market: Regional Estimates & Trend Analysis by Patch Type and Distribution Channel

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America Non-opioid Pain Patches Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Regulatory Framework
      • 6.4.2.3. Competitive Insights
      • 6.4.2.4. U.S. Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Regulatory Framework
      • 6.4.3.3. Competitive Insights
      • 6.4.3.4. Canada Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Regulatory Framework
      • 6.4.4.3. Competitive Insights
      • 6.4.4.4. Mexico Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe Non-opioid Pain Patches Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Framework
      • 6.5.2.3. Competitive Insights
      • 6.5.2.4. UK Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Framework
      • 6.5.3.3. Competitive Insights
      • 6.5.3.4. Germany Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Framework
      • 6.5.4.3. Competitive Insights
      • 6.5.4.4. France Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Regulatory Framework
      • 6.5.5.3. Competitive Insights
      • 6.5.5.4. Italy Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Regulatory Framework
      • 6.5.6.3. Competitive Insights
      • 6.5.6.4. Spain Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Norway
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Regulatory Framework
      • 6.5.7.3. Competitive Insights
      • 6.5.7.4. Norway Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Denmark
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Regulatory Framework
      • 6.5.8.3. Competitive Insights
      • 6.5.8.4. Denmark Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Sweden
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Regulatory Framework
      • 6.5.9.3. Competitive Insights
      • 6.5.9.4. Sweden Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Non-opioid Pain Patches Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Framework
      • 6.6.2.3. Competitive Insights
      • 6.6.2.4. Japan Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Framework
      • 6.6.3.3. Competitive Insights
      • 6.6.3.4. China Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Framework
      • 6.6.4.3. Competitive Insights
      • 6.6.4.4. India Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Framework
      • 6.6.5.3. Competitive Insights
      • 6.6.5.4. South Korea Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. Australia
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Regulatory Framework
      • 6.6.6.3. Competitive Insights
      • 6.6.6.4. Australia Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Regulatory Framework
      • 6.6.7.3. Competitive Insights
      • 6.6.7.4. Thailand Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Non-opioid Pain Patches Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Regulatory Framework
      • 6.7.2.3. Competitive Insights
      • 6.7.2.4. Brazil Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Regulatory Framework
      • 6.7.3.3. Competitive Insights
      • 6.7.3.4. Argentina Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. MEA Non-opioid Pain Patches Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Regulatory Framework
      • 6.8.2.3. Competitive Insights
      • 6.8.2.4. South Africa Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Regulatory Framework
      • 6.8.3.3. Competitive Insights
      • 6.8.3.4. Saudi Arabia Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Regulatory Framework
      • 6.8.4.3. Competitive Insights
      • 6.8.4.4. UAE Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Regulatory Framework
      • 6.8.5.3. Competitive Insights
      • 6.8.5.4. Kuwait Non-opioid Pain Patches Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. Acorda Therapeutics, Inc.
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Teva Pharmaceutical Industries Ltd.
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. GSK plc
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Endo, Inc.
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Hisamitsu Pharmaceutical Co.,Inc.
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. IBSA Institut Biochimique SA
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Alkermes
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. Teikoku Pharma
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Mylan N.V.
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global non-opioid pain patches market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 5 Global non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 6 North America non-opioid pain patches market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 8 North America non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 9 U.S. non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 10 U.S. Non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 11 Canada non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 12 Canada non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 13 Mexico non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 14 Mexico non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 15 Europe non-opioid pain patches market, by country, 2018 - 2030 (USD Million)
  • Table 16 Europe non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 17 Europe non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 18 UK non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 19 UK non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 20 Germany non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 21 Germany non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 22 France non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 23 France Non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 24 Italy non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 25 Italy non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 26 Spain non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 27 Spain non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 28 Norway non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 29 Norway Non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 30 Denmark non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 31 Denmark non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 32 Sweden non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 33 Sweden non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific non-opioid pain patches market, by country, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 37 Japan non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 38 Japan non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 39 China non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 40 China non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 41 India non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 42 India non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 43 Australia non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 44 Australia non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 45 South Korea non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 46 South Korea non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 47 Thailand non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 48 Thailand non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 49 Latin America non-opioid pain patches market, by country, 2018 - 2030 (USD Million)
  • Table 50 Latin America non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 51 Latin America non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 52 Brazil non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 53 Brazil non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 54 Argentina non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 55 Argentina non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa Non-opioid pain patches market, by country, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 58 Middle East & Africa non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 59 South Africa non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 60 South Africa non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 63 UAE non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 64 UAE non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 65 Kuwait non-opioid pain patches market, by patch type, 2018 - 2030 (USD Million)
  • Table 66 Kuwait non-opioid pain patches market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Non-opioid pain patches market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Patch type and distribution channel outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 Non-opioid pain patches market dynamics
  • Fig. 12 Non-opioid pain patches market: Porter's five forces analysis
  • Fig. 13 Non-opioid pain patches market: PESTLE analysis
  • Fig. 14 Non-opioid pain patches market: Patch type segment dashboard
  • Fig. 15 Non-opioid pain patches market: Patch type market share analysis, 2024 & 2030
  • Fig. 16 Lidocaine patches market, 2018 - 2030 (USD Million)
  • Fig. 17 Diclofenac patches market, 2018 - 2030 (USD Million)
  • Fig. 18 Methyl salicylate patches market, 2018 - 2030 (USD Million)
  • Fig. 19 Capsaicin patches market, 2018 - 2030 (USD Million)
  • Fig. 20 Ketoprofen patches market, 2018 - 2030 (USD Million)
  • Fig. 21 Others (herbal, menthol, etc.) market, 2018 - 2030 (USD Million)
  • Fig. 22 Non-opioid pain patches market: Distribution channel segment dashboard
  • Fig. 23 Non-opioid pain patches market: Distribution channel market share analysis, 2024 & 2030
  • Fig. 24 Retail pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 25 Hospital pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 26 Online pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 27 Others (supermarkets/hypermarkets, DTC) market, 2018 - 2030 (USD Million)
  • Fig. 28 Non-opioid pain patches market revenue, by region
  • Fig. 29 Regional marketplace: Key takeaways
  • Fig. 30 Regional marketplace: Key takeaways
  • Fig. 31 North America non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. country dynamics
  • Fig. 33 U.S. non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 34 Canada country dynamics
  • Fig. 35 Canada non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 36 Mexico country dynamics
  • Fig. 37 Mexico non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 38 Europe non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 39 UK country dynamics
  • Fig. 40 UK non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 41 Germany country dynamics
  • Fig. 42 Germany non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 43 France country dynamics
  • Fig. 44 France non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 45 Italy country dynamics
  • Fig. 46 Italy non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 47 Spain country dynamics
  • Fig. 48 Spain non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 49 Norway country dynamics
  • Fig. 50 Norway non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 51 Sweden country dynamics
  • Fig. 52 Sweden non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 53 Denmark country dynamics
  • Fig. 54 Denmark non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 55 Asia Pacific non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 56 Japan country dynamics
  • Fig. 57 Japan non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 58 China country dynamics
  • Fig. 59 China non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 60 India country dynamics
  • Fig. 61 India non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 62 Australia country dynamics
  • Fig. 63 Australia non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 64 South Korea country dynamics
  • Fig. 65 South Korea non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 66 Thailand country dynamics
  • Fig. 67 Thailand non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 68 Latin America non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 69 Brazil country dynamics
  • Fig. 70 Brazil non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 71 Argentina country dynamics
  • Fig. 72 Argentina non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 73 MEA non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 74 South Africa country dynamics
  • Fig. 75 South Africa non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 76 Saudi Arabia country dynamics
  • Fig. 77 Saudi Arabia non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 78 UAE country dynamics
  • Fig. 79 UAE non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 80 Kuwait country dynamics
  • Fig. 81 Kuwait non-opioid pain patches market, 2018 - 2030 (USD Million)
  • Fig. 82 Company categorization
  • Fig. 83 Company market position analysis
  • Fig. 84 Strategic framework